Alzheimer disease: open trials in Puerto Rico

9 open trials have a site in Puerto Rico. Registry data; only the trial team decides who can take part.

NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Trial Treatment · Phase 3 · Bristol-Myers Squibb
San Juan · CMRC Headlands, San Juan · Instituto De Neurologia Dra. Ivonne Fraga, San Juan
Registry updated 2026-11-03
NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Trial Treatment · Phase 3 · Eli Lilly and Company
SCB Research Center, Bayamón
Registry updated 2026-10-28
NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Bayamón · Bayamón · San Juan · San Juan · Instituto De Neurologia Dra. Ivonne Fraga,Psc, San Juan
Registry updated 2026-10-27
NCT06976216
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Instituto De Neurologia Dra. Ivonne Fraga, San Juan
Registry updated 2026-10-27
NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Trial Treatment · Phase 3 · Hoffmann-La Roche
University of Puerto Rico - Medical Science Campus, San Juan
Registry updated 2026-10-19
NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Bayamón · Bayamón · Carolina · San Juan · Barbara Diaz Hernandez MD Research Inc, San Juan
Registry updated 2026-10-16
NCT06976203
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
SCB Research Center, Bayamón
Registry updated 2026-10-08
NCT05552157
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Trial Treatment · Phase 2/3 · Washington University School of Medicine
University of Puerto Rico, School of Medicine, San Juan
Registry updated 2026-07-27
NCT06647498
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Trial Treatment · Phase 2/3 · Washington University School of Medicine
University of Puerto Rico, School of Medicine, San Juan
Registry updated 2026-07-27

All Alzheimer disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error